A rare case of atorvastatin causing reversible hearing loss.
The hearing loss fully reversed upon stopping the atorvastatin. Afterward, the patient was switched to rosuvastatin with no problems.
Link to article:
Research Communities by Springer NatureJMCR Highlight: When a Common Cholesterol-Lowering Drug Becomes the Cause of Hearing Loss: A Reversible Case of Atorvastatin-Associated Sensorineural Hearing LossStatins are among the most frequently prescribed medications worldwide, yet auditory toxicity is rarely recognized. This JMCR case highlights reversible bilateral sensorineural hearing loss associated with atorvastatin, emphasizing the importance of early recognition and prompt drug withdrawal.communities.springernature.comQuoted:
Atorvastatin has an established role in reducing cardiovascular morbidity and mortality and is generally considered safe. However, this case reminds clinicians that even widely prescribed medications may rarely produce unexpected neurological or otological complications.
A 45-year-old Ethiopian woman developed bilateral tinnitus followed by progressive, symmetric sensorineural hearing loss approximately three weeks after starting atorvastatin 40 mg daily. She had no history of noise exposure, chronic ear disease, head trauma, or exposure to other ototoxic medications. Audiometry confirmed bilateral moderate sensorineural hearing loss, while evaluation excluded alternative metabolic, infectious, and autoimmune causes.
The temporal relationship between drug initiation and symptom onset prompted discontinuation of atorvastatin. Improvement was already evident after one week, with complete normalization of hearing thresholds and full resolution of tinnitus by one month. Subsequent treatment with rosuvastatin was well tolerated, with no recurrence during six months of follow-up.


